Welcome to our dedicated page for Usana Health Sciences news (Ticker: USNA), a resource for investors and traders seeking the latest updates and insights on Usana Health Sciences stock.
USANA Health Sciences, Inc. (NYSE: USNA) is a global nutrition company that develops and manufactures nutritional supplements, functional foods, personal care products, skincare, and healthy living products. This news page aggregates coverage of USANA’s announcements, giving readers a focused view of how the company communicates about its business, products, and strategic priorities.
Investors and observers can use this page to follow USANA’s updates on net sales outlooks, segment performance, and guidance, as reflected in press releases tied to events such as investor conferences and quarterly results. The company issues news on its direct selling operations, its Hiya direct-to-consumer segment, and its Rise Wellness business, including commentary on growth expectations, investments in inventory and capital expenditures, and integration initiatives.
USANA also publishes product-focused news, such as third-party certifications for its Probiotic and MagneCal D supplements, which have earned the ConsumerLab.com Seal of Approval. These items highlight the company’s emphasis on purity, potency, and scientific standards for its nutritional products. Additional stories cover partnerships, including its collaboration with the Jamaica Bobsleigh and Skeleton Federation, and community initiatives led by the USANA Foundation to address food insecurity.
Leadership and culture are recurring themes in USANA’s communications, with messages from its Executive Chairman and CEO on growth mindset, values-based leadership, and social wellness. By visiting this page regularly, readers can track how USANA presents its strategy, product quality, philanthropy, and international footprint through official news releases.
Summary not available.
USANA Health Sciences, Inc. (NYSE:USNA), a leader in nutritional supplements, has announced that CFO Doug Hekking will participate in investor conferences. Key events include the 35th Annual Roth Conference in Dana Point, CA on March 13, 2023, and the D.A. Davidson Consumer Growth Conference in New York, NY on March 21, 2023, with a presentation scheduled for 1:15 PM EDT.
Webcasts for these conferences will be accessible via the 'IR Calendar' section of USANA's website. USANA offers a range of high-quality health products sold directly to customers in various countries, including the U.S., Canada, and Australia.
Summary not available.
USANA Health Sciences, Inc. congratulates Jessica Arias, the executive director of marketing, on being named to Utah Business magazine's 40 Under 40 list on February 23, 2023. Jessica leads USANA's global marketing efforts, significantly contributing to successful product launches across 24 markets. Her leadership is highlighted by peers, with commendations from Dan Macuga and Ashley Collins, emphasizing her dedication and impact within the company. The Utah Business award recognizes outstanding young professionals who have achieved notable success.
USANA Health Sciences, Inc. (NYSE: USNA) has announced a leadership transition, effective July 1, 2023. Kevin Guest, CEO since 2015, will become Executive Chairman, while Jim Brown, previously President, will take over as CEO. Guest expressed gratitude for his team and confidence in Brown's leadership qualities. Brown emphasized his commitment to advancing USANA’s mission and expanding its market presence. The Board recognizes Guest’s contributions and believes this transition positions USANA for continued growth and success in the health and wellness sector.
USANA Health Sciences, Inc. (USNA) reported its financial results for the fourth quarter and fiscal year 2022, showing a fourth-quarter net sales decline to $228 million from $267 million year-over-year. Q4 diluted EPS fell to $0.66 from $1.03. Full year net sales were $999 million, down 16% from $1,186 million in 2021, with diluted EPS declining 37% to $3.59. The company reiterated its FY 2023 outlook, projecting net sales between $850 million to $950 million and diluted EPS of $2.35 to $3.30.
The active customer base was 490,000, a 13% decrease from the previous year.
Summary not available.
USANA Health Sciences (NYSE: USNA) has introduced an Affiliate Program, aimed at expanding its customer and entrepreneur base. The program is currently available in the US, Canada, and Mexico, allowing affiliates to earn 15%–20% commissions on product sales through personal links. CEO Kevin Guest stated that this initiative would help USANA adapt to evolving customer expectations and drive growth. Executive VP Jeannie Price highlighted the program's potential to attract a new market segment, offering customers a chance to earn while sharing their favorite USANA products.
USANA Health Sciences (NYSE: USNA) reported preliminary fiscal year 2022 results, anticipating net sales of approximately
Kevin Guest, chairman and CEO of USANA Health Sciences (NYSE: USNA), launches a motivational campaign for January's National Rising Star Month, encouraging individuals to embrace new habits and take risks. Drawing from his bestselling book, All the Right Reasons: 12 Timeless Principles for Living a Life in Harmony, Guest emphasizes the importance of stepping out of comfort zones to discover inner strength. He identifies five key rewards of starting new habits, including increased self-confidence and improved ability to handle stress. Proceeds from his book support feeding hungry children.